IRIS
ABELTINO, Manuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.347
AS - Asia 1.172
EU - Europa 934
SA - Sud America 132
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 46
OC - Oceania 1
Totale 3.707
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.293
SG - Singapore 386
CN - Cina 364
IT - Italia 268
SE - Svezia 172
VN - Vietnam 163
FI - Finlandia 113
BR - Brasile 103
IE - Irlanda 101
DE - Germania 89
HK - Hong Kong 75
TR - Turchia 57
CA - Canada 40
ZA - Sudafrica 40
JP - Giappone 31
NL - Olanda 30
UA - Ucraina 26
BD - Bangladesh 23
GB - Regno Unito 23
IN - India 20
CI - Costa d'Avorio 19
FR - Francia 19
RO - Romania 16
AT - Austria 14
BE - Belgio 14
ES - Italia 9
MX - Messico 9
PL - Polonia 9
AR - Argentina 8
EC - Ecuador 8
ID - Indonesia 8
KR - Corea 8
RU - Federazione Russa 8
CZ - Repubblica Ceca 6
PH - Filippine 6
VE - Venezuela 6
IQ - Iraq 4
UY - Uruguay 4
CH - Svizzera 3
DZ - Algeria 3
EE - Estonia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
PK - Pakistan 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
LK - Sri Lanka 2
LT - Lituania 2
PT - Portogallo 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
CM - Camerun 1
EU - Europa 1
GD - Grenada 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
Totale 3.662
Salva come PNG Salva come JPEG
Città #
Singapore 222
Ashburn 165
San Jose 115
Dublin 100
Santa Clara 100
Chandler 91
Ann Arbor 85
Dallas 77
Hong Kong 70
Beijing 64
Parma 61
Jacksonville 54
Ho Chi Minh City 49
Council Bluffs 48
Izmir 41
Nanjing 41
Johannesburg 40
Hefei 34
Los Angeles 32
Munich 32
Dearborn 31
Tokyo 31
Boardman 29
Bologna 27
New York 26
Hanoi 23
San Mateo 21
Shanghai 21
Toronto 20
Abidjan 19
Buffalo 18
Focsani 16
Princeton 16
Jinan 15
Lauterbourg 15
Nanchang 15
Shenyang 15
Brussels 14
Falls Church 14
Kunming 14
Columbus 13
Milan 13
Des Moines 11
Montreal 11
Helsinki 10
São Paulo 10
Wilmington 10
Haiphong 9
Phoenix 9
Vienna 9
Bremen 8
Dong Ket 8
Hangzhou 8
Hebei 8
Jiaxing 8
Kocaeli 8
Seoul 8
Turku 8
Warsaw 8
Düsseldorf 7
Poplar 7
Arzano 6
Boston 6
Changsha 6
Frankfurt am Main 6
Guangzhou 6
Hải Dương 6
Modena 6
Moscow 6
Piacenza 6
Porto Alegre 6
Redmond 6
Seattle 6
Ankara 5
Brooklyn 5
Cambridge 5
Jakarta 5
Orem 5
Reggio Emilia 5
Rome 5
Stockholm 5
Taizhou 5
Tianjin 5
Verona 5
Atlanta 4
Biên Hòa 4
Da Nang 4
Houston 4
Langhirano 4
Mexico City 4
Novara 4
Pune 4
Quito 4
Savignano Sul Rubicone 4
Springfield 4
The Dalles 4
Woodbridge 4
Zhengzhou 4
Almaty 3
Amsterdam 3
Totale 2.301
Salva come PNG Salva come JPEG
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 322
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 286
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 265
The Pharmacological Blockade of Phosphodiesterase IV Potentiates the Anti-Tumor Effects of Arsenic Trioxide (ATO) in Acute Myelogenous Leukemia Cells through Multiple Signaling Pathways 256
Are the Myeloma bone microevironment cells tumoral or not? 233
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 201
CC-4047 (Pomalidomide) inhibits multiple myeloma-induced osteoclast formation targeting RANKL in the bone marrow microenvironment 190
HOXB7 is a key gene involved in Myeloma cell growth and Myeloma-induced angiogenesis in Multiple Myeloma patients 183
Oxygen tension in the bone marrow (BM) of patients with malignant and indolent monoclonal gammopathy: role of hypoxia and hypoxia-inducible factor (HIF)-1{alpha} in the regulation of gene expression and pro-angiogenic profiles of CD138+ cells 177
The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules 172
HOXB7 is critically involved in Multiple Myeloma-induced angiogenic switch 167
The IMID CC-4047 (Pomalidomide) inhibits myeloma-induced osteoclast formation 167
Myeloma cells inhibit the non-canonical wnt co-receptor ror2 in human mesenchymal/osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on mm-induced impairment of the osteogenic differentiation process 164
The homeobox gene HOXB7 regulates the production of pro-angiogenic molecole by myeloma cells and it is a target in myeloma-induced angiogenesis 162
In vitro and In vivo evidences of osteocytes involvement in myeloma-induced osteolysis 157
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 156
Non canonical wnt signal pathway (Wnt5a/ror2) activation stimulates the osteogenic differentiation process of bone mesenchymal cells being a potential target in multiple myeloma bone disease 151
Increased osteocyte apoptosis in Multiple Myeloma patients: a potential role in bone remodeling alterations related to osteolytic bone lesions 151
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 123
La Nutlin-3 potenzia l’effetto citotossico del trattamento combinato con gli inibitori di MEK1 e l’arsenico triossido in cellule di Leucemia Acuta 24
Totale 3.707
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022162 0 0 0 31 9 10 20 18 9 11 25 29
2022/2023402 56 53 35 26 46 29 14 9 110 5 15 4
2023/2024220 17 13 13 7 24 38 19 9 7 15 10 48
2024/2025656 51 31 24 49 70 84 32 17 97 39 69 93
2025/20261.298 108 110 184 152 160 89 106 73 152 92 52 20
2026/2027215 25 81 59 50 0 0 0 0 0 0 0 0
Totale 3.707